[33 Pages Report]The European hemostats and sealants market is projected to reach USD 89 million by 2024 from USD 63 million in 2019, at a CAGR of 7.0%. The growth of this market is majorly driven by the launch of new products and favorable reimbursement scenario. However, the shift toward minimally invasive surgeries and adverse effect of hemostats are the major factors restraining the growth of this market.
By product, the European hemostats and sealants market (for focused brands) is segmented into Tachosil, Lyostypt, Sangustop, Veriset, Avitene, and Hemopatch. Tachosil accounts for the largest market share and is anticipated to grow at the highest CAGR during the forecast period. This share can be attributed to high awareness about the brand among end users in European countries.
The European hemostats and sealants market is geographically segmented into Germany, UK, France, Italy, and Spain. While Germany dominated the market in 2019, the UK is expected to register the highest CAGR in the market during the forecast period. Germany holds the largest share amongst all the European countries, owing to its larger patient population and comparatively higher number of surgeries, which will require the usage of hemostats and sealants.
Some of the prominent players in the European hemostats and sealants market are B. Braun (Germany), Medtronic (Ireland), C. R. Bard (US), Takeda (Japan), and Baxter (US).
Market Size Available for Years
Base Year Considered
European hemostats and sealants market, by focused brands
Germany, UK, France, Italy and Spain
Major 5 players covered, including
This research report categorizes the European hemostats and sealants (focused brands) market into the following segments and subsegments:
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1.1 Objectives of the Study
1.2 Markets Covered
1.3 Years Considered for the Study
1.5 Assumptions & Limitations
2 Research Methodology
2.1 Market Breakdown and Data Triangulation
2.2 Forecast Model Steps
3 Executive Summary
4 Market Overview
4.1 Respondent Profile
4.3 Market Dynamics
4.4 Sealing Products
5 Hemostats Market, By Product & Country
List of Tables (8 Tables)
Table 1 European Hemostats and Sealants Market (USD Million), By Brand, 2017 - 2024
Table 2 European Hemostats and Sealants Market (USD Million), By Country, 2017 - 2024
Table 3 Sangustop Market (USD Million), By Country, 2017 - 2024
Table 4 Lyostypt Market (USD Million), By Country, 2017 - 2024
Table 5 Avitene Market (USD Million), By Country, 2017 - 2024
Table 6 Tachosil Market (USD Million), By Country, 2017 - 2024
Table 7 Hemopatch Market (USD Million), By Country, 2017 - 2024
Table 8 Veriset Market (USD Million), By Country, 2017 - 2024
List of Figures (6 Figures)
Figure 1 Brand Market, Country
Figure 2 Country Presence
Figure 3 Number of Respondents, By Type
Figure 4 Number of Respondents, By Country
Figure 5 Supply Side Respondents, By Type
Figure 6 Demand Side Respondents, By Designation
The study involved four major activities to estimate the current size of the hemostats and sealants (focused brands) market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.
Several stakeholders such as manufacturers, distributors, surgeons, and physicians from academic and government institutes were consulted for this report. The demand side of this market is characterized by the significant use of focused hemostats and sealants due to the favorable reimbursement scenario in European countries. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the European hemostats and sealants (focused products) market. The research methodology used to estimate the market size includes the following:
To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the hemostats and sealants industry.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Benchmarking the rapid strategy shifts of the Top 100 companies in the European Hemostats & Sealants MarketRequest For Special Pricing